Selective impairment of drug-metabolizing enzymes in pig liver during subchronic dietary exposure to aflatoxin B1

Food and Chemical Toxicology

Volumn 45, Issue 11, 2007, Pages 2145-2154

  Meissonnier, Guylaine M ^a,b   Laffitte, Joelle ^a   Loiseau, Nicolas ^a   Benoit, Etienne ^c   Raymond, Isabelle ^d   Pinton, Philippe ^a   Cossalter, Anne Marie ^a   Bertin, Gérard ^b   Oswald, Isabelle P ^a   Galtier, Pierre ^a  

^a CEMAGREF   (France)

^b ALLTECH INC   (United States)

^c VETAGRO SUP   (France)

^d UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Aflatoxin B1; Cytochrome P450; Liver; P450 1A; P450 3A; Swine

Indexed keywords

AFLATOXIN B1; AMINOPHENAZONE; BENZPHETAMINE; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 2C; CYTOCHROME P450 3A; ETHOXYRESORUFIN DEETHYLASE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; LIVER ENZYME; TESTOSTERONE; TRANSFERASE; UNSPECIFIC MONOOXYGENASE;

AFLATOXICOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; DEGENERATION; DIETARY INTAKE; ENZYME ACTIVITY; EXPOSURE; LIVER FAILURE; LIVER FIBROSIS; LIVER TOXICITY; LONG TERM EXPOSURE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PIGLET; PROTEIN EXPRESSION; TESTOSTERONE METABOLISM; WEIGHT GAIN;

ANIMALIA; SUIDAE;

EID: 34548824804     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2007.05.012     Document Type: Article

References (47)

1. Anzenbacher P., Soucek P., Anzenbacherova E., Gut I., Hruby K., Svoboda Z., and Kvetina J. Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples. Drug Metab. Dispos. 26 (1998) 56-59
2. Arlotto M.P., Trant J.M., and Estabrook R.W. Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function. Meth. Enzymol. 206 (1991) 454-462
3. Azziz-Baumgartner E., Lindblade K., Gieseker K., Rogers H.S., Kieszak S., Njapau H., Schleicher R., McCoy L.F., Misore A., DeCock K., Rubin C., and Slutsker L. Case-control study of an acute aflatoxicosis outbreak, Kenya, 2004. Environ. Health Perspect. 113 (2005) 1779-1783
4. Carrillo M.C., Carnovale C.E., and Monti J.A. Effect of aflatoxin B1 treatment in vivo on the in vitro activity of hepatic and extrahepatic glutathione S-transferase. Toxicol. Lett. 50 (1990) 107-116
5. Cochin J., and Axelrod J. Biochemical and pharmacological changes in the rat following chronic administration of morphine nalorphine and normorphine. J. Pharmacol. Exp. Ther. 125 (1959) 105-110
6. Council of Agricultural Science and Technology, 2003. Mycotoxins: Risk in Plant, Animal, and Human Systems. Report No. 139. C.A.S.T., Ames, Iowa.
7. Desille M., Corcos L., L'Helgoualc'h A., Fremond B., Campion J.P., Guillouzo A., and Clement B. Detoxifying activity in pig livers and hepatocytes intended for xenotherapy. Transplantation 68 (1999) 1437-1443
8. Donato M.T., Castell J.V., and Gomez-Lechon M.J. Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models. J. Hepatol. 31 (1999) 542-549
9. Eaton, D.L., Ramsdell, H.S., Neal, G.E., 1994. Biotransformation of aflatoxins. In: Academic Press Inc. (Eds.), The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance, pp. 45-65.
10. Frei J. Multiplicity and specificity of UDP-glucuronyltransferase. I. Effect of divalent cations and EDTA on the activity of UDP-glucuronyltransferase assayed with bilirubin, 4-methylumbelliferone and p-nitrophenol. Enzymol. Biol. Clin. (Basel) 11 (1970) 385-401
11. Gallagher E.P., Wienkers L.C., Stapleton P.L., Kunze K.L., and Eaton D.L. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1. Cancer Res. 54 (1994) 101-108
12. Gallagher E.P., Kunze K.L., Stapleton P.L., and Eaton D.L. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol. Appl. Pharmacol. 141 (1996) 595-606
13. Galtier P., Battaglia A., More J., and Franc M. Impairment of drug metabolism by the liver in experimental fascioliasis in the rat. J. Pharm. Pharmacol. 35 (1983) 729-733
14. Galtier P., Larrieu G., and Le Bars J. Comparative incidence of oral ochratoxicosis and aflatoxicosis on the activity of drug-metabolizing enzymes in rat liver. Toxicol. Lett. 23 (1984) 341-347
15. Gawai K.R., Vodela J.K., Dalvi P.S., and Dalvi R.R. Comparative assessment of the effect of aflatoxin B1 on hepatic dysfunction in some mammalian and avian species. Comp. Biochem. Physiol. C 101 (1992) 415-418
16. Groopman J.D., and Kensler T.W. Role of metabolism and viruses in aflatoxin-induced liver cancer. Toxicol. Appl. Pharmacol. 206 (2005) 131-137
17. Guerre P., Eeckhoutte C., Larrieu G., Burgat V., and Galtier P. Dose-related effect of aflatoxin B1 on liver drug metabolizing enzymes in rabbit. Toxicology 108 (1996) 39-48
18. Guerre P., Larroque C., Pineau T., Burgat V., and Galtier P. Reduced cytochrome P450 and increased heme oxygenase in liver during rabbit aflatoxicosis. Life Sci. 58 (1996) 1883-1889
19. Guerre P., Larrieu G., Burgat V., and Galtier P. Cytochrome P450 decreases are correlated to increased microsomal oxidative damage in rabbit liver and primary cultures of rabbit hepatocytes exposed to AFB1. Toxicol. Lett. 104 (1999) 117-125
20. Guerre P., Pineau T., Costet P., Burgat V., and Galtier P. Effects of AFB1 on CYP 1A1, 1A2 and 3A6 mRNA, and P450 expression in primary culture of rabbit hepatocytes. Toxicol. Lett. 111 (2000) 243-251
21. Habig W.H., Pabst M.J., and Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249 (1974) 7130-7139
22. Harvey R.B., Huff W.E., Kubena L.F., Corrier D.E., and Phillips T.D. Progression of aflatoxicosis in growing barrows. Am. J. Vet. Res. 49 (1988) 482-487
23. Kuilman M.E., Maas R.F., and Fink-Gremmels J. Cytochrome P450-mediated metabolism and cytotoxicity of aflatoxin B(1) in bovine hepatocytes. Toxicol. In Vitro 14 (2000) 321-327
24. Kunze T. Purification and characterization of class alpha and Mu glutathione S-transferases from porcine liver. Comp. Biochem. Physiol. B - Biochem. Mol. Biol. 116 (1997) 397-406
25. La Du B.N., Mandel H.G., and Way E.L. Determination of microsomal aniline hydroxylase. In: La Du B.N., Mandel H.G., and Way E.L. (Eds). Fundamentals of Drugs Metabolism and Drug Disposition (1972), Waverly Press, Baltimore 569-572
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
27. Lake B.G. Preparation and characterization of microsomal fractions for studies on xenobiotic metabolism. In: Snell K., and Mullock B. (Eds). Biochemical Toxicology (1987), IRL Press, Oxford, UK 183-215
28. Marin D.E., Taranu I., Bunaciu R.P., Pascale F., Tudor D.S., Avram N., Sarca M., Cureu I., Criste R.D., Suta V., and Oswald I.P. Changes in performance, blood parameters, humoral and cellular immune responses in weanling piglets exposed to low doses of aflatoxin. J. Anim. Sci. 80 (2002) 1250-1257
29. Marvasi, L., Marin, D.E., Viadere, J.-L., Laffitte, J., Oswald, I.P., Galtier, P., Loiseau, N., 2006. Interaction between fumonisin B1 and pig liver cytochrome P450. In: Proceedings of the XIth International IUPAC Symposium on Mycotoxins and Phycotoxins, pp. 135-143.
30. Meissonnier G.M., Oswald I.P., and Galtier P. Aflatoxicosis in swine - A bibliographic review of clinical cases and experimental data. Revue Méd. Vét. 156 (2005) 591-605
31. Meissonnier, G.M., Marin, D.E., Galtier, P., Bertin, G., Taranu, I., Oswald, I.P., 2006. Modulation of the immune response by a group of fungal food contaminant, the aflatoxins. In: Mengheri, E., Roselli, M., Britti, M.S., Finamore, A. (Eds.), Nutrition and Immunity, Research Signpost, Kerala, pp. 147-166.
32. Myers M.J., Farrell D.E., Howard K.D., and Kawalek J.C. Identification of multiple constitutive and inducible hepatic cytochrome P450 enzymes in market weight swine. Drug Metab. Dispos. 29 (2001) 908-915
33. Nash T. The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem. J. 55 (1953) 416-421
34. Nebbia C., Dacasto M., Rossetto Giaccherino A., Giuliano Albo A., and Carletti M. Comparative expression of liver cytochrome P450-dependent monooxygenases in the horse and in other agricultural and laboratory species. Vet. J. 165 (2003) 53-64
35. Omura T., and Sato R. The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties. J. Biol. Chem. 239 (1964) 2379-2385
36. Oswald I.P., Marin D.E., Bouhet S., Pinton P., Taranu I., and Accensi F. Immunotoxicological risk of mycotoxins for domestic animals. Food. Addit. Contam. 22 (2005) 354-360
37. Raisuddin S., Parmar D., Zaidi S.I., Singh K.P., Verma A.S., Seth P.K., and Ray P.K. Aflatoxin induces depletion of activities of phase I biotransformation enzymes in growing rats. Eur. J. Drug Metab. Pharmacokin. 19 (1994) 163-168
38. Shen H.M., Shi C.Y., Lee H.P., and Ong C.N. Aflatoxin B1-induced lipid peroxidation in rat liver. Toxicol. Appl. Pharmacol. 127 (1994) 145-150
39. Soucek P., Zuber R., Anzenbacherova E., Anzenbacher P., and Guengerich F.P. Minipig cytochrome P450 3A, 2A and 2C enzymes have similar properties to human analogs. BMC Pharmacol. 1 (2001) 11
40. Steyn P.S. Mycotoxins, general view, chemistry and structure. Toxicol. Lett. (1995) 843-851
41. Tachibana S., and Tanaka M. Simultaneous determination of testosterone metabolites in liver microsomes using column-switching semi-microcolumn high-performance liquid chromatography. Anal. Biochem. 295 (2001) 248-256
42. Tapia M.O., and Seawright A.A. Experimental combined aflatoxin B1 and ochratoxin A intoxication in pigs. Aust. Vet. J. 62 (1985) 33-37
43. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76 (1979) 4350-4354
44. Tukey R.H., and Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 581-616
45. van Heugten E., Spears J.W., Coffey M.T., Kegley E.B., and Qureshi M.A. The effect of methionine and aflatoxin on immune function in weanling pigs. J. Anim. Sci. 72 (1994) 658-664
46. Wang H., Dick R., Yin H., Licad-Coles E., Kroetz D.L., Szklarz G., Harlow G., Halpert J.R., and Correia M.A. Structure-function relationships of human liver cytochromes P450 3A: aflatoxin B1 metabolism as a probe. Biochemistry 37 (1998) 12536-12545
47. Wojnowski L., Turner P.C., Pedersen B., Hustert E., Brockmoller J., Mendy M., Whittle H.C., Kirk G., and Wild C.P. Increased levels of aflatoxin-albumin adducts are associated with CYP3A5 polymorphisms in The Gambia, West Africa. Pharmacogenetics 14 (2004) 691-700